Priority Date: 05.12.11 (US 201161566828P)

THERAPEUTIC USE OF ANTI-CD22 ANTIBODIES FOR INDUCING TROGOCYTOSIS

  • Application ID: EP12856410
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 2000
Headquarter in Munich
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61, C07, C12, and G01. Kanzlei bohmann is specialized in the combination A61, C07, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 51 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 05.12.2011 - Priority Date (US 201161566828P)
  • 13.06.2013 - Publication A1 (WO2013085893)
  • 15.10.2014 - Publication A1 (EP2788020)